CSL Behring US|Life Saving Biotherapies|Plasma Protein Biotherapeutics

CSL Behring is committed to saving lives and improving the quality of life for people with rare and serious diseases worldwide. Our life-saving biotherapies are used in the treatment of hemophilia, von Willebrand disease, immune deficiencies and genetic emphysema.

18 August 2010
US FDA Approves 24 Month Shelf Life for Hizentra^®

4 August 2010
AANP Discusses the 5 Signs & Symptoms of VWD

23 June 2010
CSL Behring Awards LEAD Grants in 4 States

18 May 2010
Locations & Host Partners Announced for 9th Annual JNC

13 May 2010
VWD Young Women’s Education Campaign with the AANP

2010 JNC Event Information

Welcome to CSL Behring, a global leader in biotherapies.

Welcome to CSL Behring,
a global leader in biotherapies.